Sagent: Pharma company cuts 81 jobs at Raleigh facility
Layoffs in the life sciences are becoming a common theme in 2023 as the industry facings financial challenges.
Read full article »
CEO
Peter Kaemmerer
Sagent Pharmaceuticals focuses on the development and commercialization of injectable pharmaceutical products for cancer, oncology and urology.
Read more